Company: BNBX
Filing Date: 2025-12-30
Form Type: 424B3
Source: 0001104659-25-125037
Chunk: 36

Company: BNB PLUS CORP.
Filing Date: 2025-12-30
Form: 424B3
Chunk 36
---
 for future
grant or issuance. The authorized and unissued shares of Common Stock and preferred stock are available for issuance without further
action by our stockholders.

Common Stock

Each stockholder of our Common
Stock is entitled to one vote for each share issued and outstanding held on all matters to be voted upon by the stockholders. Our shares
of Common Stock have no preemptive, conversion, or redemption rights. The rights, preferences, and privileges of the holders of Common
Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock. Upon the
sale of substantially all of our stock or assets or dissolution, liquidation or winding up, and after all liquidation preferences payable
to any series of preferred stock entitled thereto have been satisfied, our remaining assets shall be distributed to all holders of Common
Stock and any similarly situated stockholders who are not entitled to any liquidation preference or, if there be an insufficient amount
to pay all such stockholders, then ratably among such holders. All of our issued and outstanding shares of Common Stock are fully paid
and non-assessable. The holders of shares of our Common Stock will be entitled to such cash dividends as may be declared from time to
time by the Board from funds available therefor.

The shares of Common Stock
offered by this prospectus, when issued and paid for, will also be fully paid and non-assessable.

Our Common Stock is listed
on The Nasdaq Capital Market under the symbol “BNBX.” The transfer agent and registrar for our Common Stock is Equiniti Trust
Company, LLC. The transfer agent and registrar’s address is 28 Liberty Street, Floor 53, New York, NY 10005.

Warrants

Duration, Exercise Price and Exercisability

On October 3, 2025,
pursuant to the Cash Securities Purchase Agreement, we issued to certain of the Selling Stockholders (i) Cash Pre-Funded Warrants
to purchase up to 2,070,912 shares of Common Stock and (ii) Series E-1 Warrants to purchase up to 4,620,485 shares of Common
Stock. In addition, in connection with the closing of the Cash Private Placement, we also issued (i) to the Placement Agent, Placement
Agent Warrants to purchase up to 403,236 shares of Common Stock, (ii) to the Strategic Advisor, Advisory Warrants to purchase up